0001209191-16-138764.txt : 20160826 0001209191-16-138764.hdr.sgml : 20160826 20160826135155 ACCESSION NUMBER: 0001209191-16-138764 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160824 FILED AS OF DATE: 20160826 DATE AS OF CHANGE: 20160826 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 161854160 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-08-24 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2016-08-24 4 M 0 6500 36.30 A 274725 D Common Stock 2016-08-24 4 S 0 1100 96.73 D 273625 D Common Stock 2016-08-24 4 S 0 1000 98.74 D 272625 D Common Stock 2016-08-24 4 S 0 100 99.50 D 272525 D Common Stock 2016-08-24 4 S 0 1500 101.21 D 271025 D Common Stock 2016-08-24 4 S 0 2800 101.83 D 268225 D Common Stock 13286 I 401k Common Stock 2016-08-24 4 S 0 100 100.02 D 79100 I Common Stock Held In Trust Common Stock 2016-08-24 4 S 0 900 101.60 D 78200 I Common Stock Held In Trust Stock Option (Right to Buy) 36.30 2016-08-24 4 M 0 6500 0.00 D 2017-01-23 Common Stock 6500 131500 D Transaction made pursuant to the holder's company approved trading plan under Rule 10b5-1. The holder undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $96.73 (range $96.40 to $97.37). Open market sales reported on this line occurred at a weighted average price of $98.74 (range $98.37 to $99.19). Open market sales reported on this line occurred at a weighted average price of $101.21 (range $100.63 to $101.60). Open market sales reported on this line occurred at a weighted average price of $101.83 (range $101.63 to $102.45). Open market sales reported on this line occurred at a weighted average price of $101.60 (range $101.25 to $102.00). Fully vested. Omar White, Attorney-In-Fact 2016-08-26